GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Replek AD (XMAE:REPL) » Definitions » Owner Earnings per Share (TTM)

Replek AD (XMAE:REPL) Owner Earnings per Share (TTM) : 1,087.90 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Replek AD Owner Earnings per Share (TTM)?

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Replek AD's Owner Earnings per Share (TTM) ended in Dec. 2023 was MKD1,087.90. It's Price-to-Owner-Earnings ratio for today is 13.79.


The historical rank and industry rank for Replek AD's Owner Earnings per Share (TTM) or its related term are showing as below:

XMAE:REPL' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.35   Med: 11.41   Max: 196.43
Current: 14.25


During the past 13 years, the highest Price-to-Owner-Earnings ratio of Replek AD was 196.43. The lowest was 8.35. And the median was 11.41.


XMAE:REPL's Price-to-Owner-Earnings is ranked better than
78.7% of 432 companies
in the Drug Manufacturers industry
Industry Median: 26.74 vs XMAE:REPL: 14.25

Replek AD's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was MKD-82.65. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was MKD755.42. It's PE Ratio (TTM) ratio for today is 19.86.

Replek AD's EPS without NRI for the three months ended in Sep. 2024 was MKD-101.80. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was MKD1,640.94. It's PE Ratio without NRI ratio for today is 9.14.


Replek AD Owner Earnings per Share (TTM) Historical Data

The historical data trend for Replek AD's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Replek AD Owner Earnings per Share (TTM) Chart

Replek AD Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec19 Dec20 Dec21 Dec22 Dec23
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 755.32 320.99 52.44 323.49 1,087.90

Replek AD Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Sep24
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1,087.90 - -

Competitive Comparison of Replek AD's Owner Earnings per Share (TTM)

For the Drug Manufacturers - Specialty & Generic subindustry, Replek AD's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Replek AD's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Replek AD's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Replek AD's Price-to-Owner-Earnings falls into.



Replek AD Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Replek AD's Owner Earnings per Share (TTM) Calculation:

Last Year Average of Last 5 Years
Net Income 281
Depreciation, Depletion and Amortization 65
Change In Deferred Tax 0
5Y Average of Maintenance Capital Expenditure 83
Change In Working Capital 2
Shares Outstanding (Diluted Average) 0

1. Start with "Net Income" from income statement. Replek AD's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was MKD281 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Replek AD's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Dec. 2023 was MKD65 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Replek AD's Change In Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2023 was MKD0 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = MKD83 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous year. If the revenue decreased from the previous year, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous year, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Replek AD's 5-Year Average Maintenance Capital Expenditure = MKD83 Mil

5. "Change In Working Capital" is from cashflow statement. Replek AD's Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 was MKD2 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Replek AD's Shares Outstanding (Diluted Average) for the months ended in Dec. 2023 was 0.244 Mil.

Replek AD's Onwer Earnings Per Share for Dec. 2023 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 280.628 +65.019+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-82.6164+2.416)/0.244
=1,087.90

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=14999.00/1,087.90
=13.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Replek AD Owner Earnings per Share (TTM) Related Terms

Thank you for viewing the detailed overview of Replek AD's Owner Earnings per Share (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


Replek AD Business Description

Industry
Traded in Other Exchanges
N/A
Address
Kozle 188, Skopje, MKD
Replek AD is engaged in the development, design and production of generic medicines. The company develops drugs in different pharmaceutical therapeutic categories including anti-platelet, lipid-lowering, atypical antipsychotic, anti-infective, among others. It manufactures drugs in different forms including tablets, capsules, oral solutions, creams and ointments. Its product portfolio consists of Clopidogrel, Atorvastatin, Simvastatin, risperidone, Clarythromycin, Ciprofloxacin, Meloksikam, Risperidon, terazosin, among others. Replek also offers cannabis oil products, food supplements and cosmetics.